Summary
The purpose of this study was to determine the expression levels of IL-17 in serum and IL-17 receptor (IL-17R) in intestinal mucosa tissue in patients with ulcerative colitis (UC) and con-trols, and evaluate their relationship with disease activity and explore the role of IL-17 in the patho-genesis of UC. A total of 36 Chinese UC patients and 60 healthy controls were enrolled in this study. Serum IL-17 and C-reactive protein (CRP) levels were determined by ELISA and immu-nonephelometry, respectively. The IL-17R mRNA expression levels were detected by quantitative PCR. Serum IL-17 levels were significantly elevated in UC patients as compared with those in the healthy controls (P<0.05). Among UC patients, serum IL-17 levels were significantly increased in active phase as compared with those in inactive phase (P<0.05), and correlated with CRP levels (r=0.578, P<0.01). IL-17R expression levels were higher in active UC patients than in healthy con-trols (P<0.05). It was concluded that IL-17 levels were highly expressed in UC, especially in active phase, and correlated with CRP levels in UC patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Shih DQ, Targan SR. Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol, 2008, 14(3):390–400
Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol, 2010,28:573–621
Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest, 2007, 117(3):514–521
Kobayashi T, Okamoto S, Hisamatsu T, et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease. Gut, 2008,57(12): 1682–1689
Rovedatti L, Kudo T, Biancheri P, et al. Differential regulation of interleukin-17 and interferon-γ production in inflammatory bowel disease. Gut, 2009,58(12): 1629–1636
Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implication. Gut, 2006, 55(12):749–753
Oikonomou KA, Kapsoritakis AN, Kapsoritaki AI, et al. Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease. Inflamm Bowel Dis, 2011,17(4):963–970
Andoh A, Yagi Y, Shioya M, et al. Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol, 2008,14(33):5154–5161
Fuss IJ, Neurath M, Boirivant M, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol, 1996,157(3):1261–1270
Fuss IJ, Heller F, Boirivant M, et al. Nonclassical CD1d restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest, 2004,113(10):1490–1497
Elson CO, Cong Y, Weaver CT, et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology, 2007,132(7)359–2370
Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 cells. Annu Rev Immunol, 2009,27:485–517
Rao DA, Eid RE, Qin L, et al. Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection. J Exp Med, 2008,205:(13):3145–3158
Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol, 2006, 177(1):566–573
Zhang Z, Zheng M, Bindas J, et al. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis, 2006,12:(5)382–388
Hovhannisyan Z, Treatman J, Littman DR. Characterization of IL-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology, 2011,140(3): 957–965
Yang XO, Chang SH, Park H, et al. Regulation of inflammatory responses by IL-17F. J Exp Med, 2008,205(5):1063–1075
Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut, 2003,52(1):65–70
Kinugasa T, Sakaguchi T, Gu X, et al. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology, 2000,118(6):1001–1011
O’Connor W Jr, Kamanaka M, Booth CJ, et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol, 2009,10(6): 603–609
Mieliauskaite D, Dumalakiene I, Rugiene R, et al. Expression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjögren's syndrome. Clin Dev Immunol, 2012,2012:187258
Vincent FB, Northcott M, Hoi A, et al. Clinical associations of serum interleukin-17 in systemic lupus erythematosus. Arthritis Res Therapy, 2013,15(4):R97
Author information
Authors and Affiliations
Corresponding author
Additional information
This project was supported by the National Natural Science Foundation of China (No. 81200283)
Rights and permissions
About this article
Cite this article
Zhang, H., Xia, B., Li, J. et al. Expression and clinical significance of IL-17 and IL-17 receptor in ulcerative colitis. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 36, 37–40 (2016). https://doi.org/10.1007/s11596-016-1538-2
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-016-1538-2